Large-scale testing (Phase 3)Study completedNCT02846532
What this trial is testing
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Who this might be right for
Thrombosis
Janssen Research & Development, LLC 112